Maarten van der Doelen

Chapter 3

REFERENCES

1. Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fossa SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213-23. 2. Morris MJ, Corey E, Guise TA, Gulley JL, Kevin KellyW, Quinn DI, et al. Radium-223 mechanism of action: implications for use in treatment combinations. Nat Rev Urol. 2019;16(12):745-56. 3. Ritter MA, Cleaver JE, Tobias CA. High-LET radiations induce a large proportion of non rejoining DNA breaks. Nature. 1977;266(5603):653-5. 4. Suominen MI, Fagerlund KM, Rissanen JP, Konkol YM, Morko JP, Peng Z, et al. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clin Cancer Res. 2017;23(15):4335-46. 5. Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DL. Whole-Body and Microenvironmental Localization of Radium-223 in Naive and Mouse Models of Prostate Cancer Metastasis. J Natl Cancer Inst. 2016;108(5):djv380. 6. Wu Q, Allouch A, Martins I, Brenner C, Modjtahedi N, Deutsch E, et al. Modulating BothTumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness. Front Immunol. 2017;8:613. 7. Malamas AS, Gameiro SR, Knudson KM, Hodge JW. Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas’ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation. Oncotarget. 2016;7(52):86937-47. 8. Kim JW, Shin MS, Kang Y, Kang I, Petrylak DP. Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer. Clin Genitourin Cancer. 2018;16(2):e469-e76. 9. Balazs K, Kis E, Badie C, Bogdandi EN, Candeias S, Garcia LC, et al. Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients. Cancers (Basel). 2019;11(9):1324. 10. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47. 11. Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, et al. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016;34(12):1402-18. 12. Wickham H, Averick M, Bryan J, Chang W, McGowan L, François R, et al. Welcome to the Tidyverse. Journal of Open Source Software. 2019;4(43):1686. 13. Wickham H, Dana S. Scales: Scale Functions for Visualization. 2020 [Available from: https:// scales.r-lib.org. 14. Wilke C. Cowplot: Streamlined Plot Theme and Plot Annotations for“ggplot2”. 2019 [Available from: https://wilkelab.org/cowplot/. 15. Clarke E, Sherrill-Mix S. Ggbeeswarm: Categorical Scatter (Violin Point) Plots. 2017 [Available from: https://github.com/eclarke/ggbeeswarm.

70